MEDICA 2022
k8凯发国际官网入口 is a global medical technology company for minimally invasive diagnostic, establishing R&D centers in both China and Japan Besides, k8凯发国际官网入口 has obtained FDA-/CE- and PDMA-certifications for their products and applied patents in China as well as overseas. The company aims to increase market penetration with excellent products and be the preferred brand trusted by doctors and patients around the world through the continuous improvement of its core technologies.
MEDICA 2022 k8凯发国际官网入口’s booth
Revolutionizing medical technology
Driven by the goal of integrating research and development in medical technology, k8凯发国际官网入口 is cooperating with many clinics and medical centers. k8凯发国际官网入口 pursues the approach of globalization and wants to supply clinics and doctors all over the world with its innovative products. Due to the high-quality standards and their strong networking and partnerships with leading hospitals and industry, k8凯发国际官网入口 has already achieved many successes. Last week, k8凯发国际官网入口 signed strategic cooperation agreement with Shanghai First Maternity and Infant Hospital, which is one of the earliest provincial and municipal maternal and child health centers in China, to build up a Gynecological Endoscopic Diagnosis and Treatment Joint Innovation Center.
With solid in-house R&D capabilities, k8凯发国际官网入口 has built a unique technology platform based on five synergistic core technologies: 4K UHD medical imaging technology, Fluorescence medical imaging technology, 3D medical imaging technology, Ultrathin Endoscopic imaging technology and Single-use Endoscopic technology. With its comprehensive portfolio of endoscope products, k8凯发国际官网入口 aims to cover all types of endoscopic procedures and meet various medical needs in this field.
k8凯发国际官网入口’s single-use endoscope family shown at MEDICA 2022
k8凯发国际官网入口's products covers both flexible and rigid endoscopy, as well as single-use and reusable endoscopes. Thanks to its cutting-edge technology, k8凯发国际官网入口's products can deliver unique advantages in the field of medical endoscopy. For example, it is the only company that obtained FDA approvals for both its 4K UHD imaging system and 4K UHD endoscopes.
k8凯发国际官网入口’s endoscope imaging system shown at MEDICA 2022
MEDICA 2022: A complete success
With its appearance at MEDICA 2022 in Düsseldorf, k8凯发国际官网入口 was able to show that its technologies, such as its 3D Visualization System, its 4K UHD endoscopes or its 4K UHD fluorescence imaging system and single-use endoscopes family, among others, are important technical tools in the diagnosis of diseases.
MEDICA 2022: k8凯发国际官网入口’s endoscope imaging system
"For us, the focus is always on the patients, for whom we want to provide optimal care. Accordingly, MEDICA 2022 was a complete success for us. We were able to convince trade fair participants of the quality of our products," said Michael Li, Vice President of International Marketing & Sales. "Furthermore, we were able to learn a lot about competitor products, and despite a really high and strong competition, we are sure that we will be able to play a decisive role in the European MedTech market in the coming years due to the quality of our products," Mr. Li continued.
MEDICA 2022: visitor experiences k8凯发国际官网入口’s 4K UHD endoscopes
Strategic cooperation confirmed to further drive globalization
k8凯发国际官网入口's single-use broncho videoscope is a flexible disposable endoscope with many advantages. Compared to conventional reusable endoscopes, single-use endoscopes (also known as disposable endoscopes) are designed to meet the growing demands of mitigating the risks of cross-contamination and hospital-acquired diseases, therefore enhancing patient safety. Their disposable nature frees healthcare practitioners from having to sterilize the used endoscope after each operation, thereby enabling back-to-back procedures and improving diagnosis and treatment efficiency. Disposable endoscopes are one of the major researches and development focuses in the field of endoscopy. Particularly amid the outbreak of COVID-19 pandemic, single-use endoscopes are the first choice for the clinical departments of respiratory. Also, according to Frost & Sullivan, the global market value for medical endoscopes was approximately $20.3 billion in 2020 and continues to grow rapidly. * By collaborating with Fujifilm Europe, k8凯发国际官网入口 secures a strategic competitive advantage over other brands, which means that an increased presence from the young company from China can also be expected in the coming years.
About k8凯发国际官网入口
Founded in 2016, k8凯发国际官网入口 is a medical device company that provides minimally invasive diagnosis and treatment solutions, and focuses on the research, development and commercialization of medical endoscopes and related products. k8凯发国际官网入口 takes ‘Globalization’ as its core strategy and has established R&D centers both in China and Japan. With solid in-house R&D capabilities, k8凯发国际官网入口 has established a unique technology platform built upon five synergistic core technologies and built a comprehensive portfolio of endoscope products and products candidates covering all types of endoscope procedures conducted by the various clinical departments, to address diverse medical needs. Adhering its value of ‘Clinical Focus’ ‘Collaborative Innovation’ ‘People Oriented’ ‘Excellence & Efficiency’, k8凯发国际官网入口 will continuously upgrade its core technologies, improve market penetration with excellent products, and to be the preferred brand trusted by doctors and patients around the world.
For more information, please visit: scivitamedical.com/#/
Press contact
WE Communications GmbH
WE-Scivita@we-worldwide.com
